Quantity of eligible people: CDEC talked over the uncertainty in the quantity of patients with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some people that are categorized as getting moderate or reasonable illness may have a critical bleeding https://hemgenix48593.blog5.net/81099020/what-does-hemgenix-mean